DarioHealth Corp (NASDAQ:DRIO)
| 3.28 Delayed Data As of Sep 29 |  +0.05 / +1.55%Today’s Change | 2.55 Today|||52-Week Range 6.78 | -23.36% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $89.3M |
Company Description
DarioHealth Corp. is a digital health company which offers a user-centric multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
Contact Information
DarioHealth Corp. 18 West 18th Street New York New York 10011 |
Employees
Shareholders
| Other institutional | 30.89% |
| Mutual fund holders | 2.45% |
| Individual stakeholders | 10.94% |
Top Executives
| Erez Raphael | Chief Executive Officer & Director |
| Richard Allen Anderson | President & General Manager-North America Region |
| Joshua Fischer | SVP-Operations & Compliance |
| Zvi Ben-David | Chief Financial Officer, Secretary & Treasurer |
| Michal Hershkovitz | Vice President-Clinical, Regulatory Affairs & QA |
